Figure 5.
Effect of ago-miR-186 transfection on HPACs. (A) Expression of miR-186 after transfection with ago-miR-186. (B) Expression of YAP1 mRNA after transfection with ago-miR-186. (C) Viability of HPACs after transfection with ago-miR-186, as determined by MTT assay. *P<0.05 and **P<0.01 vs. NC. HPACs, human pulmonary aortic endothelial cells; NC, negative control.